News | Radial Access | March 08, 2016

Merit Medical Announces First European ThinkRadial Education Course

Course is designed to provide training to interventionalists on the transradial approach

Merit Medical, ThinkRadial training course, radial interventional access, first in Europe

March 8, 2016 — Merit Medical Systems Inc. announced that the first ThinkRadial course to be held at its European headquarters in Maastricht, the Netherlands, took place Feb. 25-26. The ThinkRadial program serves to educate and train interventional cardiologists, interventional radiologists and vascular surgeons around the world about using the radial artery, as an alternative to the femoral artery, to gain access for interventional procedures.

The two-day ThinkRadial course, which began in the United States in 2014, provides a full spectrum of didactic and hands-on educational opportunities. This course marks the first in a series of two-day course offerings slated for 2016 at Merit’s European HQ, in addition to ThinkRadial courses in the U.S. and workshops and symposia throughout the year around the world.

The course will feature two concurrent tracks for interventional cardiologists and interventional radiologists, and will be held in Merit’s new training center that features hands-on training modules, including flow models for radial and femoral catheterization and pulsatile puncture arms. The Interventional Cardiology track will be proctored by Tom Kiernan, M.D., of Limerick Hospital, Limerick, Ireland; and the Interventional Radiology track will be led by Darren Klass, M.D., of Vancouver General Hospital & UBC Hospital in Vancouver, British Columbia, Canada. In addition to the course proctors, Ferdinand Kiemeneij, M.D., regarded as the “father of transradial intervention,” will speak as a special guest of honor about his experience with radial access and his vision for the future of the technique.

“I am honored to join the esteemed faculty at this European training event to discuss the benefits of transradial approach for interventional procedures,” said Kiemeneij. “Transradial intervention is rapidly gaining acceptance globally, and I believe that training and education are paramount to increasing adoption and bringing this option to patients worldwide. I look forward to participating in this course and educating attendees on the latest science and research about the radial approach and my experience in performing this procedure.”

For more information:

Related Content

American College of Cardiology Expands Patient Navigator Program
News | Cath Lab | March 21, 2018
March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help impro
Videos | Cath Lab | March 15, 2018
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer
News | Cath Lab | February 27, 2018
The American College of Cardiology (ACC) and the Saudi Arabian Cardiac Interventional Society have partnered to...
News | Cath Lab | February 23, 2018
February 23, 2018 — CorFlow Therapeutics AG announced that the company will present new insights into the coronary mi
Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Overlay Init